title: Early initial therapy of advanced follicular lymphoma: the need for vigilance.
authors.affiliation: Cleveland Clinic Taussig Cancer Institute, Cleveland, OH 44195, USA. sweetej@ccf.org
authors.forename: John W
authors.initials: JW
authors.lastname: Sweetenham
authors.forename: Arnold S
authors.initials: AS
authors.lastname: Freedman
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy* / Q000473:pathology; D020360:Neoadjuvant Therapy / Q000379:methods*; D011159:Population Surveillance / Q000379:methods; D000069283:Rituximab; D014740:Vidarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine